Cargando…

Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis

Portal vein thrombosis seems to be dependent on local hypercoagulation and venous stasis; data regarding endothelial damage are lacking. METHODS: von Willebrad factor, a marker of endothelial damage/perturbation, factor VIII, and lipopolysaccharides (LPS) were studied in the portal and systemic circ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Praktiknjo, Michael, Trebicka, Jonel, Carnevale, Roberto, Pastori, Daniele, Queck, Alexander, Ettorre, Evaristo, Violi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145026/ https://www.ncbi.nlm.nih.gov/pubmed/32032127 http://dx.doi.org/10.14309/ctg.0000000000000123

Ejemplares similares

Portal vein thrombosis in patients with cirrhosis
por: von Köckritz, Leona, et al.
Publicado: (2017)

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS
por: Queck, Alexander, et al.
Publicado: (2020)

Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis
por: Pieper, Claus Christian, et al.
Publicado: (2021)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
por: Basili, Stefania, et al.
Publicado: (2018)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
por: Queck, Alexander, et al.
Publicado: (2019)

Cerebral Sinus and Venous Thrombosis Associated with von Willebrand Factor, Independently of Factor VIII
por: Terashima, Mari, et al.
Publicado: (2008)

Etiology and Complications of Portal Vein Thrombosis
por: Trebicka, Jonel, et al.
Publicado: (2014)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Acquired Portosystemic Shunts in Cirrhosis and Portal Vein Thrombosis: A Case Report
por: Durgham, Anthony, et al.
Publicado: (2022)

Subcellular platelet factor VIII antigen and von Willebrand factor
Publicado: (1975)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2016)

Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis
por: Basili, Stefania, et al.
Publicado: (2019)

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
por: Herath, Chandana B., et al.
Publicado: (2022)

Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt
por: Praktiknjo, Michael, et al.
Publicado: (2019)

Alteration of contrast enhanced ultrasound (CEUS) of hepatocellular carcinoma in patients with cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS)
por: Chang, Johannes, et al.
Publicado: (2020)

Combination of Fat-Free Muscle Index and Total Spontaneous Portosystemic Shunt Area Identifies High-Risk Cirrhosis Patients
por: Faron, Anton, et al.
Publicado: (2022)

Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

How to keep the factor VIII/von Willebrand factor complex in the circulation
por: Denis, Cécile V., et al.
Publicado: (2021)

Subunit Flexibility of Multimeric von Willebrand Factor/Factor VIII Complexes
por: Parker, Ernest T., et al.
Publicado: (2022)

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

Role of circulating angiogenin levels in portal hypertension and TIPS
por: Queck, Alexander, et al.
Publicado: (2021)

Conformation of the von Willebrand factor/factor VIII complex in quasi-static flow
por: Parker, Ernest T., et al.
Publicado: (2021)

Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study
por: Wang, Hong-Liang, et al.
Publicado: (2021)

AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal vein
por: Kuetting, Daniel, et al.
Publicado: (2018)

von Willebrand Factor, Free Hemoglobin and Thrombosis in ECMO
por: Valladolid, Christian, et al.
Publicado: (2018)

Successful desensitization in a patient with Von Willebrand´s disease and anaphylaxis to factor VIII/VW
por: Olival, Maristela, et al.
Publicado: (2014)

Presence of factor VIII-related antigen in blood platelets of patients with Von Willebrand's disease
por: BOUMA, B. N., et al.
Publicado: (1975)

Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study
por: Goudemand, Jenny, et al.
Publicado: (2020)

Anticoagulation and Transjugular Intrahepatic Portosystemic Shunting for Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis
por: Davis, Jessica P. E., et al.
Publicado: (2019)

Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis
por: Guo, Ding-Fan, et al.
Publicado: (2022)

Cyclic GMP in Liver Cirrhosis—Role in Pathophysiology of Portal Hypertension and Therapeutic Implications
por: Kreisel, Wolfgang, et al.
Publicado: (2021)

Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity
por: Hollestelle, Martine J., et al.
Publicado: (2011)

Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability
por: Negreva, Mariya Negrinova, et al.
Publicado: (2020)

Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro
por: Montilla, Marcela, et al.
Publicado: (2022)

Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding
por: Casini, Alessandro, et al.
Publicado: (2023)

Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease
por: Lapić, Ivana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_npvm0ok0s0l6e4sd252mn7v0i1